NewsBenzingaB. Riley证券启动对Cue生物制药的覆盖，并给予买入评级，宣布股价目标为83美元 B. Riley证券启动对Cue生物制药的覆盖，并给予买入评级，宣布股价目标为83美元 Benzinga 2026.09.18 10:39 (GMT+0) Open on Benzinga Other news Pre-market US stocks: Memory sector broadly higher, Micron Technology (MU.O) up 2.40% Musk announces he will gift one SpaceX share to every child in the U.S. next year JPMorgan Extends JPM Coin to Ethereum for Institutional Clients Morgan Stanley: Raises Meta target price from $775 to $820 JPMorgan Expands Its Deposit Token JPM Coin to Ethereum, Opening It to Institutional Clients Nasdaq Tumbles Over 2%, Records Weekly Loss: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone
Nasdaq Tumbles Over 2%, Records Weekly Loss: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone
